Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 15/20 | 0.49 |
| ▸ | PGR | P06401 | 12/20 | 0.46 |
| ▸ | NR3C2 | P08235 | 12/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4855085 | 1.00 | NR3C1 (0.49) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| Benzene SCHEMBL4861506 | 0.99 | NR3C1 (0.50) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| Benzene SCHEMBL4862993 | 0.99 | NR3C1 (0.50) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| SCHEMBL197733 | 0.97 | NR3C1 (0.51) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| SCHEMBL2959369 | 0.97 | NR3C1 (0.51) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| SCHEMBL2959368 | 0.97 | NR3C1 (0.51) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| SCHEMBL7523866 | 0.97 | NR3C1 (0.51) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| SCHEMBL990146 | 0.97 | NR3C1 (0.51) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| SCHEMBL2956892 | 0.97 | NR3C1 (0.51) | NR3C1PGRNR3C2L3MBTL1LMNA | |
| SCHEMBL7617103 | 0.97 | NR3C1 (0.51) | NR3C1PGRNR3C2L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332622-B2 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGUKU KABUSHIKI KAISHA (JP) | 2008-02-19 | — | — | US | disclosed |
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2005-05-12 | — | — | US | disclosed |
| EP-1512678-A1 | Process for preparing optically active nitro compounds and cyano compounds | Kanto Kagaku Kabushiki Kaisha (JP) | 2005-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | NOS1, NOS2, NOX1 | NR3C1 3425/4885PGR 4654/4885NR3C2 3772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.